Verastem

VSTM

Verastem Oncology (Verastem Inc) is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.

Verastem has been a target of short sellers for a while. The current short interest of 20.20% is roughly at the average of the last 12 months (20.38%).